All answers

•Starts plasma exchange (x3) and steroids
•LDH decrease, but platelets and creatinine remain abnormal
•Shiga toxin: negative
•No evident underlying causes – normal B12
•ADAMTS13: 45%
What do we do next?


  • Start caplacizumab and rituximab, without plasma exchange
  • Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16362
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • All answers

Reminder

FINISH

Time is up